XNAS: GRCE
Grace Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Grace Therapeutics Inc is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its development pipeline consists of the following product candidates: GTx-104, a novel injectable formulation of nimodipine for the tr...
Read More
2.10
0.00
(0.00%)
874.1
XNAS Volume
XNAS 22 Sep, 2026 9:35 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Grace Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..